Avanos Medical, Inc. (AVNS)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Avanos Medical, Inc. (AVNS) is up 122.4% since the beginning of the year. At $25 per share, AVNS is trading just below its 52-week high of $25. Investors who bought $1,000 worth of AVNS shares 5 years ago would now be looking at an investment worth $638.

Avanos Medical, Inc. (AVNS) has returned 122.44% so far this year and 100.64% over the past 12 months. Over the last ten years, AVNS has returned -2.53% per year, falling short of the S&P 500 Index benchmark, which averaged 13.66% annually.

Based on dividend-adjusted daily data since Oct 21, 2014, AVNS's average daily return is +0.02%, while the average monthly return is +0.32%. At this rate, an investment would double in approximately 18.1 years.

Historically, 50% of months were positive and 50% were negative. The best month was Apr 2026 with a return of +75.7%, while the worst month was Jan 2016 at -25.8%. The longest winning streak lasted 7 consecutive months, and the longest losing streak was 4 months.

On a daily basis, AVNS closed higher 50% of trading days. The best single day was Apr 14, 2026 with a return of +69.5%, while the worst single day was Nov 5, 2019 at -21.7%.

Avanos Medical, Inc. has an annualized alpha of -8.99%, beta of 1.06, and R2 of 0.19 versus S&P 500 Index. Calculated based on daily prices since October 22, 2014.

• This stock participated in 149.31% of S&P 500 Index downside but only 77.82% of its upside - more exposed to losses than it benefited from rallies.
• R2 of 0.19 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

AVNS ranks 88 for risk / return — in the top 88% of stocks on our site. This means strong returns relative to risk — exactly what professional investors look for. Well-suited for investors who want to maximize return per unit of risk.

The table below present risk-adjusted performance metrics for Avanos Medical, Inc. (AVNS) and compare them to S&P 500 Index.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Avanos Medical, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Avanos Medical, Inc. was 86.39%, occurring on Aug 5, 2025. The portfolio has not yet recovered.

The current Avanos Medical, Inc. drawdown is 65.62%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Avanos Medical, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Avanos Medical, Inc. is priced in the market compared to other companies in the Medical Devices industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.